Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
26.48
-2.18 (-7.61%)
At close: Nov 7, 2025, 4:00 PM EST
26.05
-0.43 (-1.62%)
After-hours: Nov 7, 2025, 4:21 PM EST
Janux Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts that cover Janux Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $77.4, which forecasts a 192.30% increase in the stock price over the next year. The lowest target is $41 and the highest is $200.
Price Target: $77.4 (+192.30%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Janux Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 3 | 3 | 5 | 5 | 4 |
| Buy | 3 | 4 | 4 | 5 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 8 | 8 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $47 → $48 | Buy | Maintains | $47 → $48 | +81.27% | Nov 7, 2025 |
| Barclays | Barclays | Buy Initiates $47 | Buy | Initiates | $47 | +77.49% | Sep 17, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +277.64% | Sep 10, 2025 |
| Stifel | Stifel | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +69.94% | Sep 10, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $72 | Strong Buy | Initiates | $72 | +171.90% | Sep 4, 2025 |
Financial Forecast
Revenue This Year
2.92M
from 10.59M
Decreased by -72.38%
Revenue Next Year
5.55M
from 2.92M
Increased by 89.91%
EPS This Year
-2.33
from -1.28
EPS Next Year
-3.09
from -2.33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.5M | 63.2M | |||
| Avg | 2.9M | 5.6M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.8% | 2,060.3% | |||
| Avg | -72.4% | 89.9% | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.07 | -1.96 | |||
| Avg | -2.33 | -3.09 | |||
| Low | -3.13 | -5.39 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.